Kimberly-Clark stock (US4943681035): CCI approves Kenvue acquisition

Kimberly-Clark Corporation, the maker of Kleenex and Huggies, received approval from India's Competition Commission (CCI) for its acquisition of Kenvue Inc. The deal, outlined in a merger agreement dated November 2, 2025, gives Kimberly-Clark sole control over Kenvue, according to Law Chronicle as of May 2026. This regulatory nod advances the transaction amid ongoing portfolio shifts in the personal care sector.

The stock traded at around $102 on NYSE as of recent data, with a market cap of $32.31 billion, a PE ratio of 15.28 and beta of 0.29, per MarketBeat as of 05/13/2026. Institutional moves continue, including Global Wealth Management raising its stake and MGO One Seven trimming holdings.

As of: 13.05.2026

By the editorial team – specialized in equity coverage.

Kimberly-Clark: core business model

Kimberly-Clark Corporation manufactures and markets personal care products worldwide, operating in North America and international segments. Iconic brands like Kleenex tissues, Huggies diapers, Kotex feminine care and Scott paper products drive its consumer staples portfolio, per company profile on MarketBeat as of 05/13/2026. The firm supplies retail, healthcare and institutional channels with essentials from baby care to workplace hygiene.

Founded in 1872 in Neenah, Wisconsin, it has grown from paper mills into a global leader with $20.4 billion in 2024 annual revenue (fiscal year ended 12/31/2024, per public filings). Products span disposable diapers, training pants, incontinence items, wipes and professional wipers under brands like KleenGuard.

Main revenue and product drivers for Kimberly-Clark

Personal care accounts for the bulk of revenue, with North America contributing the lion's share. Recent quarterly revenue hit $4.16 billion, up 2.7% year-over-year and beating estimates of $4.09 billion (period ended Q1 2026, per MarketBeat as of 05/13/2026). Key drivers include volume growth in diapers and tissues amid steady US consumer demand.

EPS reached $1.93 in the quarter, with net margins at 12.80% and ROE of 152.79% (same period). Analysts project full-year 2026 EPS at 7.48. The Kenvue acquisition could bolster feminine care and add synergies in branded consumer goods.

Industry trends and competitive position

In the US consumer staples sector, Kimberly-Clark holds strong positioning with household brands facing peers like Procter & Gamble. Stable demand for essentials supports resilience, though private label competition pressures margins. Global expansion, including the approved Kenvue deal, targets emerging markets like India.

Why Kimberly-Clark matters for US investors

Listed on NYSE, Kimberly-Clark offers US investors exposure to defensive consumer staples with 50-year dividend growth history. Its low beta of 0.29 signals lower volatility versus the S&P 500, appealing amid economic uncertainty. Recent Q1 results and M&A progress highlight operational strength in the $500B+ US personal care market.

Conclusion

The CCI approval for the Kenvue acquisition represents a significant step for Kimberly-Clark's growth agenda, complementing solid Q1 results and institutional interest. With a robust brand portfolio and US market dominance, the company navigates sector dynamics effectively. Investors track integration progress and upcoming earnings for further insights into execution.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.